Debt-to-Equity Ratio

Bio-Rad's debt-to-equity ratio of 0.18x means the company uses only $0.18 of debt for every $1 of shareholders' equity, indicating low financial leverage and conservative financing.

This is well below the healthcare sector median of 0.45x, placing Bio-Rad in the 45th percentile among its peers—meaning it carries less debt than most but not the absolute least. The ratio has been stable over the last eight quarters, with no year-over-year change available, and it declined 10.0% quarter-over-quarter from 0.20x to 0.18x. The combination of a low and stable debt level with a recent decline suggests minimal financial risk from borrowing, but also implies limited use of debt for growth or leverage. This overall conservative capital structure aligns with a neutral verdict by neither signaling aggressive expansion nor impending distress. The metric supports the NEUTRAL outlook, as the low and stable debt-to-equity ratio offers a safety buffer but does not alone justify a bullish or bearish stance.

Frequently Asked Questions

Closest Sector Peers